Evidence map›Paper›PMID 26154167›Full record

ArticleStem cells and development2015

Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.

Faith A Bazley, Cyndi F Liu, Xuan Yuan, Haiping Hao, Angelo H All, Alejandro De Los Angeles, Elias T Zambidis, John D Gearhart, Candace L Kerr

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells and development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Biomaterials and cell-based therapy post spinal cord injury.Journal of translational medicine · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Early Gonadal Development and Sex Determination in Mammal.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
  9. BMP4 activates the Wnt-Journal of cell science · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Faith A Bazley1 Department of Biomedical Engineering, The Johns Hopkins University School of Medicine , Baltimore, Maryland.
Cyndi F Liu2 Department of Genecology and Obstetrics, The Johns Hopkins University School of Medicine , Baltimore, Maryland.
Xuan Yuan4 Department of Medicine, Division of Hematology, The Johns Hopkins University School of Medicine , Baltimore, Maryland.
Haiping Hao5 JHMI Deep Sequencing and Microarray Core, High Throughput Biology Center, Johns Hopkins University , Baltimore, Maryland.
Angelo H All1 Department of Biomedical Engineering, The Johns Hopkins University School of Medicine , Baltimore, Maryland.
Alejandro De Los Angeles6 Stem Cell Transplantation Program, Division of Pediatric Hematology Oncology, Children's Hospital Boston , Massachusetts.
Elias T Zambidis3 Institute for Cell Engineering, The Johns Hopkins University School of Medicine , Baltimore, Maryland.
John D Gearhart10 Department of Cell and Developmental Biology, School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Candace L Kerr2 Department of Genecology and Obstetrics, The Johns Hopkins University School of Medicine , Baltimore, Maryland.
Johns Hopkins University · USBoston Children's Hospital · USCalifornia University of Pennsylvania · USUniversity of Maryland, Baltimore · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
Basic and Translational Research of iPSC-Based hematologic and Vascular TherapiesU01HL099775 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI FRIEDMAN, ALAN D · 2009 to 2015
$8.4M
Pluripotent Stem Cell Vascular Therapies for Ischemic RetinopathiesR01EY023962 · NEI · JOHNS HOPKINS UNIVERSITY · PI ZAMBIDIS, ELIAS T. · 2014 to 2018
$1.8M
Transcriptional and Epigenetic Regulation of HSC Generated from iPS and ESCR03HL096220 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI FRIEDMAN, ALAN D, ZAMBIDIS, ELIAS T. · 2009 to 2009
$41k
NCI NIH HHS P30 CA006973NEI NIH HHS R01 EY023962PHS HHS NICHD R21HD057487
6 · The paper itself

Abstract

Primordial germ cells (PGCs) share many properties with embryonic stem cells (ESCs) and innately express several key pluripotency-controlling factors, including OCT4, NANOG, and LIN28. Therefore, PGCs may provide a simple and efficient model for studying somatic cell reprogramming to induced pluripotent stem cells (iPSCs), especially in determining the regulatory mechanisms that fundamentally define pluripotency. Here, we report a novel model of PGC reprogramming to generate iPSCs via transfection with SOX2 and OCT4 using integrative lentiviral. We also show the feasibility of using nonintegrative approaches for generating iPSC from PGCs using only these two factors. We show that human PGCs express endogenous levels of KLF4 and C-MYC protein at levels similar to embryonic germ cells (EGCs) but lower levels of SOX2 and OCT4. Transfection with both SOX2 and OCT4 together was required to induce PGCs to a pluripotent state at an efficiency of 1.71%, and the further addition of C-MYC increased the efficiency to 2.33%. Immunohistochemical analyses of the SO-derived PGC-iPSCs revealed that these cells were more similar to ESCs than EGCs regarding both colony morphology and molecular characterization. Although leukemia inhibitory factor (LIF) was not required for the generation of PGC-iPSCs like EGCs, the presence of LIF combined with ectopic exposure to C-MYC yielded higher efficiencies. Additionally, the SO-derived PGC-iPSCs exhibited differentiation into representative cell types from all three germ layers in vitro and successfully formed teratomas in vivo. Several lines were generated that were karyotypically stable for up to 24 subcultures. Their derivation efficiency and survival in culture significantly supersedes that of EGCs, demonstrating their utility as a powerful model for studying factors regulating pluripotency in future studies.

Indexed as

Cellular ReprogrammingCells, CulturedEmbryonic Stem CellsGerm CellsHumansInduced Pluripotent Stem CellsKruppel-Like Factor 4Kruppel-Like Transcription FactorsOctamer Transcription Factor-3Proto-Oncogene Proteins c-mycSOXB1 Transcription FactorsKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsOctamer Transcription Factor-3POU5F1 protein, humanProto-Oncogene Proteins c-mycSOX2 protein, humanSOXB1 Transcription Factors

Identifiers

PMID26154167
PMCPMC4652187
OpenAlexW1825262569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.